Shipman & Goodwin has a multidisciplinary team of attorneys who represent life science, medical product and healthcare technology companies, including biotechnology companies, medical device manufacturers, pharmaceutical companies, healthcare providers, tissue banks, software companies, investment banks and venture capital firms. Because our attorneys have backgrounds in business, finance, science and healthcare, we understand the business, scientific, and regulatory issues facing our clients.
We provide assistance to life sciences companies at every stage of development, from startup and emerging companies to late stage companies. We often work closely with special counsel on FDA regulatory approvals. We also represent investment banks, venture capitalists, and other debt and equity investors in the industry. Our team can provide coordinated and efficient services to life sciences companies and other industry participants, including:
To learn more about our representation of life sciences companies, click here.